Published: 6 March 2025
Publications
Quarterly summary of recent safety communications
Published: 6 March 2025
Prescriber Update 46(1): 8
March 2025
The table below is a summary of recent safety communications for healthcare professionals and consumers. Click on a specific topic to go to the communication.
| Date | Communication | Topic |
|---|---|---|
| 27/02/2025 | Monitoring | Update – Reports of pericarditis following mpox vaccination |
| 12/02/2025 | Dear Healthcare Professional Letter | Konakion MM (phytomenadione) Paediatric 2mg/0.2mL solution for injection: Temporary supply of overseas product (PDF, 2 pages, 284 KB) |
| 28/01/2025 | Dear Healthcare Professional Letter | Imbruvica: Newly identified risk of hepatotoxicity (including hepatic failure) in warnings and precautions section of the Imbruvica NZ data sheet and consumer medicine information (PDF, 4 pages, 296 KB) |
| 16/01/2025 | Monitoring |
Anti-CD20 monoclonal antibodies (rituximab, ocrelizumab, obinutuzumab,
ofatumumab) and the possible risk of pyoderma gangrenosum
|
